Sparking Transformation in Healthcare

egnite is a technology company advancing guideline-directed cardiovascular care and real-world evidence.

Sparking Transformation in Healthcare

egnite is a company with a vision:
to identify and improve outcomes for every cardiovascular patient in the U.S.

Sparking Transformation in Healthcare

egnite is a company with a vision:
to identify and improve outcomes for every cardiovascular patient in the U.S.

TURNING DATA INTO CLINICAL ACTION & iNSIGHTS

egnite's CardioCare + Registry

The CardioCare® platform is deployed at more than 80 heart programs to identify and prioritize cardiovascular patients. The egnite Registry, built on de-identified EHR data, gives life sciences and research teams a longitudinal view of the patient journey.

FOR CLINICIANS

The CardioCare Platform

Human intelligence enhanced
by artificial intelligence

The Leading Digital Health Platform for Progressive Cardiovascular Centers With Solutions Across Valve Disease Heart Failure Atrial Fibrillation Clinical Trials

FOR LIFE SCIENCES

egnite Therapy Accelerator & Research

Welcome to one of the largest ecosystems
of real-world cardiovascular data

Podcasts

egnite COO, Jessica Neufeld, discusses the current state of A.I. adoption and challenges in healthcare, along with the role of technology in improving patient care on a recent episode of Microsoft’s Data and A.I. podcast Insights Tomorrow.

egnite Senior Medical Advisor, Rahul Sharma, was recently featured on MedAxiom’s HeartTalk podcast to discuss how technology can be used to identify and treat patients before it’s too late.

Learn more from egnite CEO, Joel Portice, on how egnite is elevating the role of A.I. and big data to guide critical decisions in healthcare on Mike Moore’s The Bleeding Edge of Digital Health podcast.

Real-World Evidence

Presented or Published in

Recognition

Testimonials

Leading health systems and life sciences organizations partner with egnite to transform care delivery for cardiovascular patients.

CardioCare's A.I. tools will help us ensure that every patient receives optimal evaluation and management of their heart disease. Its big data approach will also help us identify patients who might be candidates for one of many research trials, thereby potentially giving patients access to otherwise unavailable therapeutic options.

Dr. Linda Gillam

Chair of Cardiovascular Medicine
Gagnon Cardiovascular Institute, Morristown Medical Center

This is the first time in my career I've been able to see this type of information for my program. There is always opportunity to improve, even at academic medical institutions. CardioCare is not just a platform; it's a program that can demonstrate value for structural heart programs at every level.

Dr. Rahul Sharma

Associate Professor of Medicine, Stanford University
Director of Structural Interventions, Stanford Health Care
Senior Medical Advisor, egnite

Resources

Moderate AS patients outnumbered severe AS by nearly 2:1

Majority of Patients with Moderate Aortic Stenosis Carry Features Linked to Twice the Risk of Death, egnite Registry Study Finds

November 2, 2026

The analysis, published simultaneously in JACC, found that moderate AS patients with at least one at-risk feature had a two-fold increase in mortality and hospitalization

Sparking Transformation in Healthcare

Sparking Transformation in Healthcare

Sparking Transformation in Healthcare

egnite's CardioCare + Registry

The CardioCare Platform

egnite Therapy Accelerator & Research

Podcasts

Real-World Evidence

Recognition

Testimonials

Resources

Connect with egnite.

Schedule my demo today.